Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Osi Pharmaceuticals, Inc. patentsThe following is a sampling of recent Osi Pharmaceuticals, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
June 2009 - Osi Pharmaceuticals, Inc. patents
20090163468 - Fused bicyclic mtor inhibitors
May 2009 - Osi Pharmaceuticals, Inc. patents
20090136517 - Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit
20090118499 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
April 2009 - Osi Pharmaceuticals, Inc. patents
20090099176 - Pyrrolopyridine-2-carboxylic acid amides
20090099227 - G-protein coupled receptor agonists
20090092596 - Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
20090093488 - Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
March 2009 - Osi Pharmaceuticals, Inc. patents
20090062275 - N-substituted imidazopyridine c-kit inhibitors
January 2009 - Osi Pharmaceuticals, Inc. patents
20090023703 - Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
January 2008 - Osi Pharmaceuticals, Inc. patents
20080014200 - Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
20080009060 - Methods of discovering chemicals capable of functioning as gene expression modulators
December 2007 - Osi Pharmaceuticals, Inc. patents
20070293426 - Methods for improving islet signaling in diabetes mellitus and for its prevention
20070286864 - Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
20070280928 - Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
November 2007 - Osi Pharmaceuticals, Inc. patents
20070254883 - Unsaturated mtor inhibitors
October 2007 - Osi Pharmaceuticals, Inc. patents
20070244090 - Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
20070231838 - Method for the assay of rock kinase activity in cells
20070232669 - N-phenylbenzotriazolyl c-kit inhibitors
September 2007 - Osi Pharmaceuticals, Inc. patents
20070212738 - Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
20070207946 - Dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels
20070208053 - Fused heterobicyclic kinase inhibitors
June 2007 - Osi Pharmaceuticals, Inc. patents
20070149521 - Bicyclic protein kinase inhibitors
20070129364 - Pyrrolopyridine kinase inhibiting compounds
20070129547 - Process to prepare substituted imidazopyrazine compounds
May 2007 - Osi Pharmaceuticals, Inc. patents
20070112005 - Fused bicyclic mtor inhibitors
20070099856 - Combined treatment with docetaxel and an epidermal growth factor receptor kinase inhibitor using an intermittent dosing regimen
February 2007 - Osi Pharmaceuticals, Inc. patents
20070032512 - 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors
December 2006 - Osi Pharmaceuticals, Inc. patents
20060287251 - Combination therapy for glycaemic control
November 2006 - Osi Pharmaceuticals, Inc. patents
20060252762 - Methods for treatment of multiple sclerosis
20060247275 - (2-carboxamido)(3-amino)thiophene compounds
October 2006 - Osi Pharmaceuticals, Inc. patents
20060234940 - Secondary binding site of dipeptidyl peptidase iv (dp iv)
20060223799 - Pyrrolo[2,3-d]imidazoles for the treatment of hyperproliferative disorders
September 2006 - Osi Pharmaceuticals, Inc. patents
20060211060 - Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
20060211678 - Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Osi Pharmaceuticals, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Osi Pharmaceuticals, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
